An evaluation of Haemophilus influenzae type b (Hib) vaccination and description of Risk factors for Hib vaccine failure in Europe 1996-1998
During the past decade, conjugate vaccines against Haemophilus influenzae type b (Hib) infection have been introduced for routine use in infants into several countries in Europe. Currently, the vaccination programmes in these countries differ with respect to the choice of vaccine, the schedule for primary immunisation, and the use of a booster dose in the second year of life.
Monthly measles and rubella monitoring report July 2019
19 Jul 2019 - The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for 1 June 2018 to 31 May 2019.
Hantavirus infection - Annual Epidemiological Report for 2017
15 Jul 2019 - In 2017, 21 countries reported 4 239 cases of hantavirus infection (0.8 cases per 100 000 population). Two countries, Finland and Germany, accounted for 70.1% of all reported cases. In the absence of a licensed vaccine, prevention mainly relies on rodent control, avoidance of contact and properly cleaning and disinfecting areas contaminated by rodent excreta (urine, saliva or droppings).
Tularaemia - Annual Epidemiological Report for 2017
15 Jul 2019 - For 2017, 447 cases of tularaemia were reported by 18 countries in the EU/EEA, 413 (92%) of which were confirmed. As in previous years, the proportion of cases among males was higher in all age groups, with a male-to-female ratio of 2.1:1. Notification rates in men and women increased with age (except for the age group ≥65 years). The highest rate was observed in men in the age group 45–64 years (0.2 cases per 100 000 population).